541 related articles for article (PubMed ID: 19007963)
1. The human papillomavirus E7 oncoprotein.
McLaughlin-Drubin ME; Münger K
Virology; 2009 Feb; 384(2):335-44. PubMed ID: 19007963
[TBL] [Abstract][Full Text] [Related]
2. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein.
Münger K; Basile JR; Duensing S; Eichten A; Gonzalez SL; Grace M; Zacny VL
Oncogene; 2001 Nov; 20(54):7888-98. PubMed ID: 11753671
[TBL] [Abstract][Full Text] [Related]
3. A Conserved Amino Acid in the C Terminus of Human Papillomavirus E7 Mediates Binding to PTPN14 and Repression of Epithelial Differentiation.
Hatterschide J; Brantly AC; Grace M; Munger K; White EA
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581101
[TBL] [Abstract][Full Text] [Related]
4. The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle.
Flores ER; Allen-Hoffmann BL; Lee D; Lambert PF
J Virol; 2000 Jul; 74(14):6622-31. PubMed ID: 10864676
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus type 16 E7 oncoprotein associates with E2F6.
McLaughlin-Drubin ME; Huh KW; Münger K
J Virol; 2008 Sep; 82(17):8695-705. PubMed ID: 18579589
[TBL] [Abstract][Full Text] [Related]
6. Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor.
Liu X; Clements A; Zhao K; Marmorstein R
J Biol Chem; 2006 Jan; 281(1):578-86. PubMed ID: 16249186
[TBL] [Abstract][Full Text] [Related]
7. Papillomavirus E6 proteins.
Howie HL; Katzenellenbogen RA; Galloway DA
Virology; 2009 Feb; 384(2):324-34. PubMed ID: 19081593
[TBL] [Abstract][Full Text] [Related]
8. Association of the human papillomavirus type 16 E7 protein with the S-phase-specific E2F-cyclin A complex.
Arroyo M; Bagchi S; Raychaudhuri P
Mol Cell Biol; 1993 Oct; 13(10):6537-46. PubMed ID: 8413252
[TBL] [Abstract][Full Text] [Related]
9. Papillomavirus E6 and E7 proteins and their cellular targets.
Wise-Draper TM; Wells SI
Front Biosci; 2008 Jan; 13():1003-17. PubMed ID: 17981607
[TBL] [Abstract][Full Text] [Related]
10. Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes.
Vousden K
FASEB J; 1993 Jul; 7(10):872-9. PubMed ID: 8393818
[TBL] [Abstract][Full Text] [Related]
11. Cell cycle-dependent disruption of E2F-p107 complexes by human papillomavirus type 16 E7.
Zerfass K; Levy LM; Cremonesi C; Ciccolini F; Jansen-Dürr P; Crawford L; Ralston R; Tommasino M
J Gen Virol; 1995 Jul; 76 ( Pt 7)():1815-20. PubMed ID: 9049387
[TBL] [Abstract][Full Text] [Related]
12. Cancerous inhibitor of protein phosphatase 2A contributes to human papillomavirus oncoprotein E7-induced cell proliferation via E2F1.
Zhang W; Chen H; Chen Y; Liu J; Wang X; Yu X; Chen JJ; Zhao W
Oncotarget; 2015 Mar; 6(7):5253-62. PubMed ID: 25650660
[TBL] [Abstract][Full Text] [Related]
13. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7.
Gonzalez SL; Stremlau M; He X; Basile JR; Münger K
J Virol; 2001 Aug; 75(16):7583-91. PubMed ID: 11462030
[TBL] [Abstract][Full Text] [Related]
14. [Human papillomavirus E7 oncoprotein and its role in the cell transformation].
Vallejo-Ruiz V; Velázquez-Márquez N; Sánchez-Alonso P; Santos-López G; Reyes-Leyva J
Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 2():S172-7. PubMed ID: 26462513
[TBL] [Abstract][Full Text] [Related]
15. Human Papillomavirus E7 Oncoprotein Subverts Host Innate Immunity via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes.
Lo Cigno I; Calati F; Borgogna C; Zevini A; Albertini S; Martuscelli L; De Andrea M; Hiscott J; Landolfo S; Gariglio M
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776268
[TBL] [Abstract][Full Text] [Related]
16. Association of the human papillomavirus type 16 E7 oncoprotein with the 600-kDa retinoblastoma protein-associated factor, p600.
Huh KW; DeMasi J; Ogawa H; Nakatani Y; Howley PM; Münger K
Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11492-7. PubMed ID: 16061792
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus E7 oncoprotein targets RNF168 to hijack the host DNA damage response.
Sitz J; Blanchet SA; Gameiro SF; Biquand E; Morgan TM; Galloy M; Dessapt J; Lavoie EG; Blondeau A; Smith BC; Mymryk JS; Moody CA; Fradet-Turcotte A
Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19552-19562. PubMed ID: 31501315
[TBL] [Abstract][Full Text] [Related]
19. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells.
Pagano M; Dürst M; Joswig S; Draetta G; Jansen-Dürr P
Oncogene; 1992 Sep; 7(9):1681-6. PubMed ID: 1323816
[TBL] [Abstract][Full Text] [Related]
20. Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway.
Fischer M; Uxa S; Stanko C; Magin TM; Engeland K
Sci Rep; 2017 Jun; 7(1):2603. PubMed ID: 28572607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
